CEL-SCI Corp (CVM)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $29.20M
Last updated: Nov 17, 2026 at 4:41 PM ET
CEL-SCI Corp (CVM) Statistics
CEL-SCI (CVM) has a market cap of $29.20M and an enterprise value of $27.87M. Its share count is up 155.57% from a year earlier.
Total Valuation
Enterprise value is 4.56% below the market cap, as cash exceeds debt.
| Market Cap | $29.20M |
|---|---|
| Enterprise Value | $27.87M |
| Latest price (Nov 17, 2026) | $1.66 |
Key Dates
The next earnings report is expected on Dec 28, 2026, covering the quarter ending Sep 30, 2026.
| Next Earnings Date | Dec 28, 2026 (expected) |
|---|---|
| Last Earnings Date | Aug 14, 2026 |
| Fiscal Year End | September |
Valuation Ratios
| Forward P/S | 4.9x |
|---|---|
| P/B Ratio | 2.7x |
| P/TBV Ratio | 2.7x |
Price Statistics
The stock is down 74.96% over 52 weeks and trades at its 50-day average.
| Beta (1Y) | 0.87 |
|---|---|
| 52-Week Change | -74.96% |
| 1-Month Change | -7.26% |
| 3-Month Change | +4.40% |
| 6-Month Change | -3.49% |
| 5-Year Change | -99.59% |
| 10-Year Change | -99.34% |
| Total Return (1Y) | -74.96% |
| Total Return (3Y CAGR) | -70.64% |
| Total Return (5Y CAGR) | -65.01% |
| Return vs SPY (1Y) | -86.75% |
| Max Drawdown (1Y) | -87.30% |
| Max Drawdown (3Y) | -98.95% |
| Sharpe Ratio (1Y) | -1.22 |
| Correlation with SPY (1Y) | 0.10 |
| 50-Day Average | $1.66 |
| 200-Day Average | $2.27 |
| 52-Week Range | $0.89 to $7.80 |
| RSI (14 Days) | 55.4 |
| Average Volume (20 Days) | 160.98K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.48x current liabilities, and total debt is 0.47x shareholder equity.
| Current Ratio | 1.48x |
|---|---|
| Quick Ratio | 1.42x |
| Debt / Equity | 0.47x |
| Interest Coverage | -50.19x |
Returns and Efficiency
Return on invested capital is -109.01% over the last 12 months, against a 5-year average of -85.59%.
| Return on Equity (ROE) | -207.23% |
|---|---|
| Return on Assets (ROA) | -106.31% |
| Return on Invested Capital (ROIC) | -109.01% |
| Return on Capital Employed (ROCE) | -136.92% |
| ROA (5Y Average) | -83.20% |
| ROIC (5Y Average) | -85.59% |
Scores
CVM has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Gross Profit | -$960.85K |
| Operating Income | -$22.29M |
| Pretax Income | -$22.73M |
| Net Income | -$22.70M |
| EBITDA | -$18.46M |
| EBIT | -$22.29M |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 51.31% of the $21.36M in total assets.
| Cash and Equivalents | $6.53M |
|---|---|
| Total Debt | $5.19M |
| Net Cash | $1.33M |
| Net Cash Per Share | $0.08 |
| Working Capital | $2.42M |
| Shareholder Equity | $10.96M |
| Book Value Per Share | $0.62 |
| Tangible Book Value | $10.89M |
| Tangible Book Per Share | $0.62 |
| Total Assets | $21.36M |
| Total Liabilities | $10.40M |
Balance sheet as of Jun 30, 2026.
Cash Flow
| Operating Cash Flow | -$16.75M |
|---|---|
| FCF Per Share | -$0.95 |
| Depreciation and Amortization | $3.83M |
Trailing 12 months through Jun 30, 2026.
Dividends and Yields
CVM does not pay a dividend.
| Buyback Yield | -77.89% |
|---|---|
| Shareholder Yield | -77.89% |
Stock Splits
The last split was a 1-for-30 reverse split on May 20, 2025.
| Last Split Date | May 20, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:30 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About CVM
What is CVM's market cap?
CEL-SCI has a market cap of $29.20M. Its enterprise value, which adds debt and subtracts cash, is $27.87M.
How many shares of CVM are outstanding?
CEL-SCI has 17.59M shares outstanding. The count is up 155.57% from a year earlier.
Does CVM pay a dividend?
No. CEL-SCI does not pay a dividend.
How much debt does CVM have?
CEL-SCI has $5.19M of total debt and $6.53M of cash and equivalents, a net cash position of $1.33M.
CVM pages: Overview, Charting, Earnings, Financials, Statistics, Competitors